Solventum Mobile Microphone vs OroSense

The Solventum Mobile Microphone is a mobile application that allows clinicians to dictate using the Solventum Fluency Direct Desktop Application without the need for a physical microphone attached to the PC. Once the mobile application is paired one time with a Solventum Fluency Direct User ID, the user of the application can dictate using Solventum Fluency Direct running on any physical desktop or virtual device without a need for docking, Bluetooth or physical connections. The application uses secure data transmission to stream audio from the mobile device directly to Solventum Fluency Direct running elsewhere. It builds on the same cloud-based Solventum Speech Understanding (tm) technology powering all Solventum solutions, so existing clinician voice profiles can be used easily and instantly for optimal accuracy.

OroSense is a research application developed by the Sanchez Research Lab at the University of Illinois Chicago. It uses the iPhone camera and depth-sensing technology to collect standardized measurements of tongue and mouth movements. During an assessment, authorized research personnel guide participants through a series of movements, including tongue protrusion, tongue lateralization, tongue-tip elevation, forward-and-return movement, and maximum mouth opening. OroSense records cropped camera images, depth information, task measurements, task timing, and necessary device information. Assessment data is securely uploaded to the research team’s Firebase storage and is used only for approved research purposes. The application also includes a calibration mode to verify that the device is operating correctly. Calibration recordings and measurements are not saved or uploaded. Only the calibration result and date are stored locally on the device. OroSense is an investigational research tool. It is not intended to diagnose, treat, cure, or prevent any medical condition. The application is intended for use by authorized study personnel and research participants enrolled in approved studies.